Transaction in Own Shares
|
24th November 2021 |
|
|
|
|
||
|
CRH plc Transaction in Own Shares |
|
|
||||
|
|
|
|
|
|
|
|
|
CRH plc ('CRH') announces that on 23rd November 2021 it purchased the following number of its ordinary shares (the 'ordinary shares') on Euronext Dublin from CRH's broker UBS. The ordinary shares purchased will be held as treasury shares. |
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
Euronext Dublin |
|
|
|
|
Number of ordinary shares purchased: |
2,314 |
|
|
|||
|
Highest price paid per share: |
|
€44.0900 |
|
|
||
|
Lowest price paid per share: |
|
€43.8900 |
|
|
||
|
Volume weighted average price paid: |
€43.9932 |
|
|
|||
|
|
|
|
|
|
|
|
|
The purchases form part of CRH's intention to buy back ordinary shares of up to $300 million in the period to 23rd December 2021 following its announcement on 30th September 2021 and were effected by CRH's broker as part of the Programme announced on 30th September 2021. |
|
|||||
|
Following settlement of the above transactions CRH will hold 22,260,161 of its ordinary shares in treasury which represents 2.8% of the issued ordinary share capital of CRH. Ordinary shares held in treasury do not have any voting rights. Following settlement, CRH will have 772,880,177 ordinary shares in issue (excluding treasury shares). |
|
|||||
|
|
|
|
|
|
|
|
|
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation) (also in force in the UK, from time to time, including, where relevant, pursuant to the UK's Market Abuse (Amendment) (EU Exit) Regulations 2019), a detailed breakdown of individual trades made on 23rd November 2021 by UBS on behalf of CRH as part of the buyback programme is scheduled to this announcement. |
|
|||||
|
|
||||||
|
|
|
|
|
|
|
|
|
Contact Diarmuid Enright Assistant Company Secretary Tel: 00 3531 6344340 |
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|||
|
|
|
|
|
|
||
|
Transaction Details |
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuer name: |
CRH plc |
|
|
|
|
|
LEI |
|
549300MIDJNNTH068E74 |
|
|
|
|
ISIN: |
|
IE0001827041 |
|
|
|
|
Intermediary name: |
UBS Europe SE |
|
|
||
|
Intermediary code: |
5299007QVIQ7IO64NX37 |
|
|
||
|
Time zone: |
|
GMT |
|
|
|
|
Currency: |
|
EUR |
|
|
|
|
Date of Transactions: |
23/11/2021 |
|
|
|
|
|
|
|
|
|
|
|
|
Aggregated Information |
|
|
|
|
|
|
|
|
|
|
|
|
|
Trading venue |
Currency |
Volume Weighted Average Price |
Aggregated volume |
|
|
|
Euronext Dublin (XMSM) |
EUR |
43.9932 |
2,314 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of |
Price per Share (EUR) |
Currency |
Trade Time |
Trading Venue |
MatchID |
|
439 |
43.89 |
EUR |
08:08:47 |
Euronext Dublin (XMSM) |
1612151 |
|
250 |
43.89 |
EUR |
08:08:47 |
Euronext Dublin (XMSM) |
1612149 |
|
530 |
44.02 |
EUR |
08:09:13 |
Euronext Dublin (XMSM) |
1613001 |
|
19 |
44.00 |
EUR |
08:10:37 |
Euronext Dublin (XMSM) |
1616244 |
|
527 |
44.00 |
EUR |
08:10:37 |
Euronext Dublin (XMSM) |
1616242 |
|
549 |
44.09 |
EUR |
08:12:01 |
Euronext Dublin (XMSM) |
1618917 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 31 minutes ago Touchstone Exploration Inc NPV (DI)
- 31 minutes ago Diaceutics
- 31 minutes ago Taseko Mines Limited NPV (DI)
- 31 minutes ago Taseko Mines Limited NPV (DI)
- 31 minutes ago Arecor Therapeutics